The number of U.S. employers offering travel benefits for abortion services is expected to double over the next few years in the wake of the Supreme Court's Dobbs v. Jackson Women's Health Organization decision.
A new survey by global advisory, brokering, and solutions company WTW reveals that more than a third of respondents (35 percent) currently offer travel and lodging benefits for elective and medically necessary abortions, while another 16 percent of employers plan to do so in 2023. Another 21 percent are considering adding such benefits.
The survey, which polled 305 U.S. employers, also found that nearly half (44 percent) of employers which offer, or plan to offer, travel benefits for abortion services—or for any other medical procedures, including transplant, bariatric, and musculoskeletal surgeries; gender affirmation; or fertility services—have enhanced those benefits in the wake of the Supreme Court's ruling. Another 46 percent are planning to enhance, or considering enhancing, these benefits in the future. What's more, 86 percent of employers align their travel and lodging benefits for abortion services with travel and lodging benefits for other procedures.
Complete your profile to continue reading and get FREE access to Treasury & Risk, part of your ALM digital membership.
Your access to unlimited Treasury & Risk content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Thought leadership on regulatory changes, economic trends, corporate success stories, and tactical solutions for treasurers, CFOs, risk managers, controllers, and other finance professionals
- Informative weekly newsletter featuring news, analysis, real-world case studies, and other critical content
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical coverage of the employee benefits and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
*May exclude premium content© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.